Hyderabad: The Lancet Public Health Study painted a grim picture of the rising cases of non-communicable diseases (NCDs) in Telangana.
The State-level disease trends on NCDs released by the reputed science journal on Wednesday said in the last 26 years (1990 to 2016), there was a steady rise in cardiovascular ailments, respiratory disorders and cancers in Telangana. This was recorded in every major Indian State, indicating that NCDs will be the next major threat to public health in the country.
The Lancet study employed special techniques to arrive at trends on prevalence of NCDs for recently formed States of Telangana, Chattisgarh, Jharkhand and Uttarakhand. The public health data for these States were disaggregated from their parent States on the basis of data collected from the districts.
The prevalence of Chronic Obstructive Pulmonary Diseases (COPD) in Telangana in 1990 for one lakh population was between 2,750 patients and 3,249 patients. By 2016, the COPD numbers increased and was between 4,250 patients and 4,749 patients.
Similarly, the prevalence of asthma in 1990 in Telangana was less than 2,250 patients for one lakh patients. By 2016, its prevalence increased to 2,750-3,749 patients for one lakh population.
Cardiovascular ailments too were no different, as the study said the prevalence of heart ailments increased in India from 25.7 million in 1990 to a whopping 54.7 million in 2016.
In Telangana, the prevalence of cardiovascular diseases for one lakh population in 2016 hovered between 4,000 patients and 4,499 patients, while in Andhra Pradesh the figure was higher — 4,500-5,000 patients.
The prevalence of high blood pressure for 100 patients in Telangana was less than 18 patients, while in AP, it was 23. Cholesterol levels also went up with its prevalence for 100 persons in the State hovering between 22 patients and 25 patients. In AP it was between 26 patients and 28 patients.
In the case of cancers, back in 1990, the prevalence rate for one lakh population in Telangana and AP was between 45 patients and 60 patients. In the next 26 years this rose to 72 patients in TS and 76 in AP.